Runx1 deficiency protects against adverse cardiac remodeling following myocardial infarction

Autor: McCarroll, Charlotte S., He, Weihong, Foote, Kirsty, Bradley, Ashley, McGlynn, Karen, Vidler, Francesca, Nixon, Colin, Nather, Katrin, Fattah, Caroline, H. Riddell, Alexandra, Bowman, Peter, B. Elliott, Elspeth, Bell, Margaret, Hawksby, Catherine, MacKenzie, Scott M., Morrison, Liam, Terry, Anne, Blyth, Karen, L. Smith, Godfrey, W. McBride, Martin, Kubin, Thomas, Braun, Thomas, Nicklin, Stuart A., Cameron, Ewan R., Loughrey, Christopher M.

Publikováno v: McCarroll, C S, He, W, Foote, K, Bradley, A, McGlynn, K, Vidler, F, Nixon, C, Nather, K, Fattah, C, H. Riddell, A, Bowman, P, B. Elliott, E, Bell, M, Hawksby, C, MacKenzie, S M, Morrison, L, Terry, A, Blyth, K, L. Smith, G, W. McBride, M, Kubin, T, Braun, T, Nicklin, S A, Cameron, E R & Loughrey, C M 2018, ' Runx1 deficiency protects against adverse cardiac remodeling following myocardial infarction ', Circulation, vol. 137, no. 1, pp. 57-70 . https://doi.org/10.1161/CIRCULATIONAHA.117.028911

Myocardial infarction (MI) is a leading cause of heart failure and death worldwide. Preservation of contractile function and protection against adverse changes in ventricular architecture (cardiac remodeling) are key factors to limiting progression o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3094::554970ff2b2879a8aebb06b4902175e8
https://www.pure.ed.ac.uk/ws/files/44822255/284424_1_merged_1506714906.pdf